首页> 美国卫生研究院文献>Journal of Child and Adolescent Psychopharmacology >Early Nonresponse Determined by the Clinical Global Impressions Scale Predicts Poorer Outcomes in Youth with Schizophrenia Spectrum Disorders Naturalistically Treated with Second-Generation Antipsychotics
【2h】

Early Nonresponse Determined by the Clinical Global Impressions Scale Predicts Poorer Outcomes in Youth with Schizophrenia Spectrum Disorders Naturalistically Treated with Second-Generation Antipsychotics

机译:由临床总体印象量表确定的早期无反应预测用第二代抗精神病药物自然治疗的精神分裂症频谱疾病患者的结局较差

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: The use of early responseonresponse (ER/ENR) to antipsychotics as a predictor for ultimate responseonresponse (UR/UNR) may help decrease inefficacious treatment continuation. However, data have been limited to adults, and ER/ENR has only been determined using time-consuming psychopathology rating scales. In the current study, we assessed if early improvement on the Clinical Global Impressions-Improvement (CGI-I) scale predicted UR/UNR in psychiatrically ill youth started on antipsychotic treatment.>Methods: Seventy-nine youth aged 6–19 years, with schizophrenia spectrum disorders, treated naturalistically with aripiprazole, olanzapine, quetiapine, risperidone, or ziprasidone and evaluated monthly, were divided into ER/ENR groups at week 4, using at least “minimally improved” on the CGI-I scale. Prediction using week 4 ER/ENR status for UR (CGI-I=at least “much improved”), effectiveness and adverse effect outcomes at 8–12 weeks were assessed.>Results: At 4 weeks, 45.6% of subjects were ER and 54.4% were ENR without differences regarding baseline demographic, illness, and treatment variables, except for higher age (p=0.034) and maximum risperidone dose (p=0.0043) in ENR. ER/ENR status at 4 weeks predicted UR/UNR at week 12 significantly (p<0.0001): Sensitivity=68.9%, specificity=85.3%, positive predictive value=86.1%, negative predictive value=67.4%. At weeks 4, 8, and 12, ER patients improved significantly more on the CGI-I, CGI-Severity, and Children's Global Assessment of Functioning scales, and more ER patients reached UR compared with ENR patients (83.3% vs. 34.9%, all p<0.0001). ENR patients had more extrapyramidal side effects (EPS) at weeks 4, 8, and 12 (p=0.0019–0.0079). UR was independently associated with ER (odds ratio [OR]=18.09; 95% confidence interval [CI]=4.71–91.68, p<0.0001) and psychosis not otherwise specified (NOS) (OR=4.82 [CI: 1.31–21.41], p=0.017) (r2=0.273, p<0.0001).>Conclusions: Older age and EPS were associated with ENR; ENR and schizophrenia were associated with UNR in naturalistically treated youth with schizophrenia spectrum disorders. Early CGI-I-based treatment decisions require further consideration and study.
机译:>目的:使用抗精神病药物的早期反应/无反应(ER / ENR)作为最终反应/无反应(UR / UNR)的预测指标可能有助于减少无效治疗的持续时间。但是,数据仅限于成人,而ER / ENR仅使用耗时的精神病理学评定量表确定。在本研究中,我们评估了临床总体印象改善量表(CGI-I)的早期改善是否预示着接受抗精神病药物治疗的精神病患者的UR / UNR。>方法:患有精神分裂症频谱障碍的6-19岁,自然接受阿立哌唑,奥氮平,喹硫平,利培酮或齐拉西酮治疗,每月评估一次,在第4周分为ER / ENR组,至少对CGI-I进行“最低程度的改善”规模。使用第4周的ER / ENR状态对UR(CGI-I =至少“大大改善”)进行了预测,评估了8-12周的有效性和不良反应结果。>结果::4周时,45.6 %的受试者为ER,54.4%的受试者为ENR,在基线人口统计学,疾病和治疗变量方面无差异,除了ENR中较高的年龄(p = 0.034)和最大利培酮剂量(p = 0.0043)。第4周的ER / ENR状态预测第12周的UR / UNR显着(p <0.0001):敏感性= 68.9%,特异性= 85.3%,阳性预测值= 86.1%,阴性预测值= 67.4%。在第4周,第8周和第12周,ER患者的CGI-I,CGI-Severity和儿童全球功能评估量表显着改善,与ENR患者相比,更多的ER患者达到UR(83.3%比34.9%,全部p <0.0001)。 ENR患者在第4、8和12周时有更多的锥体束外副作用(EPS)(p = 0.0019-0.0079)。 UR与ER独立相关(赔率[OR] = 18.09; 95%置信区间[CI] = 4.71–91.68,p <0.0001)和未指定的精神病(NOS)(OR = 4.82 [CI:1.31–21.41] ,p = 0.017)(r 2 = 0.273,p <0.0001)。>结论:年龄和EPS与ENR相关;在自然治疗的患有精神分裂症谱系障碍的青年中,ENR和精神分裂症与UNR相关。早期基于CGI-I的治疗决策需要进一步考虑和研究。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号